, Volume 64, Issue 3, pp 301–308 | Cite as

Xeno-free proliferation of human bone marrow mesenchymal stem cells

  • Hiroto Miwa
  • Yoshiki Hashimoto
  • Keiji Tensho
  • Shigeyuki Wakitani
  • Mutsumi Takagi
JAACT Special Issue


The proliferation of human bone marrow mesenchymal stem cells (MSCs) employing xeno-free materials not containing fetal calf serum (FCS) and porcine trypsin was investigated for the regenerative medicine of cartilage using MSCs. Four sequential subcultivations of MSCs using a medium containing 10% FCS and recombinant trypsin (TrypLESelect™) resulted in cell growth comparable to that with porcine trypsin. There was no apparent difference in the cell growth and morphology between two kinds of MSC stored in liquid nitrogen using 10% FCS plus DMSO or serum-free TC protector™. MSCs were isolated from human bone marrow cells, stored in liquid nitrogen, and sequentially subcultivated four times employing conventional materials that included FCS, porcine trypsin, and DMSO, or xeno-free materials that included serum-free medium (MesenCult-XF™), TC protector™ and TrypLESelect™. Cells in the culture using the xeno-free materials maintained typical fibroblast-like morphology and grew more rapidly than the cells in the culture using the conventional materials, while the cell surface markers of MSCs (CD90 and CD166) were well maintained in both cultures. Chondrogenic pellet cultures were carried out using these subcultivated cells and a medium containing TGFβ3 and IGF1. The pellet culture using cells grown with the xeno-free materials showed an apparently higher gene expression of aggrecan, a chondrocyte marker, than the pellet culture using cells grown with the conventional materials. Consequently, MSCs that are isolated, stored, and grown using the xeno-free materials including the serum-free medium (MesenCult-XF™), TC protector™, and recombinant trypsin (TrypLESelect™) might be applicable for regenerative medicine of cartilage.


Mesenchymal stem cell Proliferation Serum-free Xeno-free Chondrogenesis 


  1. Arai F, Ohneda O, Miyamoto T, Zhang XQ, Suda T (2002) Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation. J Exp Med 195:1549–1563CrossRefGoogle Scholar
  2. Barnes D, Sato G (1980) Methods for growth of cultured cells in serum-free medium. Anal Biochem 102:255–270CrossRefGoogle Scholar
  3. Bruder SP, Jaiswal N, Haynesworth SE (1997) Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64:278–294CrossRefGoogle Scholar
  4. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S (1998) Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 16:155–162CrossRefGoogle Scholar
  5. Caplan AI (1991) Mesenchymal stem cells. J Orthop Res 9:641–650CrossRefGoogle Scholar
  6. Caplan AI, Fink DJ, Goto T, Linton AE, Young RG, Wakitani S, Goldberg VM, Haynesworth SE (1993) Mesenchymal stem cells and tissue repair. In: Jackson DW (ed) The anterior cruciate ligament: current and future concepts. Raven Press, Ltd., New York, pp 405–417Google Scholar
  7. Clark JM, Gebb C, Hirtenstein MD (1981) Serum supplements and serum-free media: applicability for microcarrier culture of animal cells. Develop Biol Stand 47:81–91Google Scholar
  8. Dennis JE, Caplan AI (1996) Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of a H-2 Kb-tsA58 transgenic mouse. J Cell Physiol 167:523–538CrossRefGoogle Scholar
  9. Fujiwara M, Tsukada R, Tsujinaga Y, Takagi M (2007) Fetal-calf-serum-free culture of Chinese hamster ovary cells employing fish serum. Appl Microbiol Biotechnol 75:983–987CrossRefGoogle Scholar
  10. Fujiwara M, Tsukada R, Shioya I, Takagi M (2009) Effects of heat treatment and concentration of fish serum on cell growth in adhesion culture of Chinese hamster ovary cells. Cytotechnology 59:135–141CrossRefGoogle Scholar
  11. Fujiwara M, Aizu Y, Shioya I, Takagi M (2010) Fetal-calf-serum-free suspension culture of Chinese hamster ovary cells employing fish serum. J Biosci Bioeng 109:307–309CrossRefGoogle Scholar
  12. Karen B, Susanne K, Harald K, Hermann E (2004) Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22:625–634CrossRefGoogle Scholar
  13. Lazarus HM, Caplan AI (1995) Ex vivo expansion and subsequent infusion of human bone-marrow-derived stromal progenitor cells (mesenchymal stem cells)—implications for therapeutic use. Bone Marrow Transplant 16:557–564Google Scholar
  14. Majumdar MK, Haynesworth SE, Thiede MA, Marshak DR, Caplan AI, Gerson SL (1995) Culture-expanded human mesenchymal stem cells (MSCs) express cytokines and support hematopoiesis in vitro. Blood 86:1966Google Scholar
  15. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL (1998) Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Phys 176:57–66CrossRefGoogle Scholar
  16. Matsuda C, Takagi M, Hattori T, Wakitani S, Yoshida T (2005) Differentiation of human bone marrow mesenchymal stem cells to chondrocytes for construction of three-dimensional cartilage tissue. Cytotechnology 47:11–17CrossRefGoogle Scholar
  17. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 28:143–147CrossRefGoogle Scholar
  18. Shipley GD, Ham RG (1983) Multiplication of Swiss 3T3 cells in a serum-free medium. Exp Cell Res 146:249–260CrossRefGoogle Scholar
  19. Stute N, Holtz K, Bubenheim M, Lange C, Blake F, Zander AR (2004) Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 32:1212–1225CrossRefGoogle Scholar
  20. Takagi M, Nakamura T, Matsuda T, Hattori T, Wakitani S, Yoshida T (2003) In vitro proliferation of human bone marrow mesenchymal stem cells employing donor serum and basic fibroblast growth factor. Cytotechnology 43:89–96CrossRefGoogle Scholar
  21. Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E, Takagishi K, Kato Y (2001) Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288:413–419CrossRefGoogle Scholar
  22. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM (1994) Mesenchymal cell-based repair of large full-thickness defects of articular cartilage. J Bone Joint Surg Am 76:579–592Google Scholar
  23. Wakitani S, Saito T, Caplan AI (1995) Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417–1426CrossRefGoogle Scholar
  24. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM (2003) Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121:368–374CrossRefGoogle Scholar
  25. Yokoyama M, Miwa H, Maeda S, Wakitani S, Takagi M (2008) Influence of fetal calf serum on differentiation of mesenchymal stem cells during expansion. J Biosci Bioeng 106:46–50CrossRefGoogle Scholar
  26. Young RG, Butler DL, Weber W, Caplan AI, Gordon SL, Fink DJ (1998) Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 16:406–413CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Hiroto Miwa
    • 1
  • Yoshiki Hashimoto
    • 1
  • Keiji Tensho
    • 2
  • Shigeyuki Wakitani
    • 3
  • Mutsumi Takagi
    • 1
  1. 1.Division of Biotechnology and Macromolecular Chemistry, Graduate School of EngineeringHokkaido UniversitySapporoJapan
  2. 2.Department of Orthopedic SurgeryShinshu University School of MedicineMatsumoto, NaganoJapan
  3. 3.Department of Orthopedic SurgeryOsaka City University School of MedicineAbeno-ku, OsakaJapan

Personalised recommendations